Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Oral Therapy (SOT) in Elderly Patients With Metastatic Breast Cancer
2006-004848-23Phase 4Terminated
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jun 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vinorelbine and capecitabine in breast cancer and breast neoplasia (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoints: Time to progression, Tolerability profile and 2 more. Started Jun 2007; status: terminated.
02
Drugs
vinorelbinecapecitabine
03
Conditions
breast cancerbreast neoplasia
Beyond the preview
Go deeper on 2006-004848-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004848-23.